Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

People with diabetes should eat as much protein as people who don't have diabetes. In a healthy diet, roughly 10% to 35% of your daily calories should come from protein. Protein itself does not have ...

EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

SS-OCT has already been applied in the diagnosis and staging of conditions such as retinopathy of prematurity, diabetic retinopathy, age-related macular degeneration, and glaucoma, and it is expected ...

Diabetic macular edema remains an important cause of vision loss among patients with diabetes mellitus. Improved control of blood pressure and blood sugar, as well as photocoagulation, are ...

Lt. Gen. Herzi Halevi is the most senior Israeli figure to resign over the security and intelligence breakdown on Oct. 7, 2023, when thousands of Hamas-led militants carried out a land ...

Israel's Top General Resigns Over Oct. 7 Failures, Adding to Pressure on Netanyahu JERUSALEM (AP) — Israel's top general resigned Tuesday, taking responsibility for security failures tied to ...

The company says that in pre-clinical tests performed on 30 people with macular degeneration, all of the participants experienced a reading speed increase of at least 50% when using the glasses.

Ocugen announced the first patient in its OCU200 phase 1 clinical trial for diabetic macular edema (DME) has been dosed. The company describes OCU200 as a “recombinant fusion protein that consists of ...

today announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema (DME). “OCU200 has the potential to change the treatment landscape for DME ...